Stock BLTE BELITE BIO, INC
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Belite Bio, Inc

Equities

BLTE

US07782B1044

Market Closed - Nasdaq
Other stock markets
 21:00:00 16/07/2024 BST 		5-day change 1st Jan Change
48.55 USD -0.92% Intraday chart for Belite Bio, Inc -1.32% +6.12%
06-12 Belite Bio Obtains Pioneer Drug Designation for Stargardt Disease Treatment in Japan MT
06-12 Belite Bio, Inc. Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BELITE BIO, INC Stock Belite Bio, Inc
 1.46B - - - - -
MODERNA, INC. Stock Moderna, Inc.
 46.56B -
LONZA GROUP AG Stock Lonza Group AG
 41.67B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.16B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 32.4B -
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 28.18B
  1. Stock Market
  2. Equities
  3. BLTE Stock
  4. Charts Belite Bio, Inc
  5. Sector Chart